Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

Pharmaceutical technology exports have exceeded KRW 10 trillion this year, according to an Aug. 19 report based on Global ...

Despite the Trump administration's tariff threats and pressure to move more manufacturing to the U.S., the push to raise ...

Unlike traditional pharmaceutical companies that own and market their products, CFAO Healthcare South Africa operates as a ...

As per the report, Biocon Biologics Limited, which focuses on biosimilars, is particularly exposed with about 40 per cent of ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

This partnership offers a preview of the future: smarter containers that integrate renewable energy, digital visibility, and lightweight design into one solution.

The MFN executive order introduces uncertainty in pharma pricing strategies, necessitating careful risk assessment and ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...